Bayer's clotting medicine Trasylol doubled the risk of kidney failure and increased the risk of heart problems in a study reported in the New England Journal of Medicine. Bayer said the drug, used to prevent excessive bleeding in heart surgery patients, is safe based on its own studies, but the company alerted regulators about the new research results.

Related Summaries